Factors affecting upper airway control of NSAID‐exacerbated respiratory disease: A real‐world study of 167 patients
Abstract Background Nonsteroidal anti‐inflammatory drug (NSAID) exacerbated respiratory disease (N‐ERD) is a triad with asthma, chronic rhinosinusitis with nasal polyps, and NSAID intolerance. Uncontrolled N‐ERD forms a major public health problem due to frequent and difficult‐to‐treat exacerbations...
Main Authors: | Annina Lyly, Anu Laulajainen‐Hongisto, Heikki Turpeinen, Seija I. Vento, Jyri Myller, Jura Numminen, Saara Sillanpää, Johanna Sahlman, Paula Kauppi, Sanna Toppila‐Salmi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.347 |
Similar Items
-
Lung function and side effects of Aspirin desensitization: a real world study
by: Heikki Turpeinen, et al.
Published: (2021-01-01) -
Baseline Conservative and Surgical Management in the Treatment of NSAID-Exacerbated Respiratory Disease
by: Saara Sillanpää, et al.
Published: (2021-05-01) -
Monoclonal Antibodies and Airway Diseases
by: Annina Lyly, et al.
Published: (2020-12-01) -
Pathomechanisms of AERD—Recent Advances
by: Annina Lyly, et al.
Published: (2021-09-01) -
Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
by: Esha Sehanobish, et al.
Published: (2021-06-01)